This evidence strengthens the proposition that stress-induced adrenergic activation modulates tumor phenotype, particularly through HIF-1α and the Wnt/β-catenin pathway, thereby potentiating CSC-driven resistance to DOX. This evidence concerns the gene HIF1A and neoplasm.